image
Akebia Therapeutics, Inc. AKBA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.79
-3.76 %
$ 391 M
Market Cap
-8.14
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -33.49% 51.02% 26.79%
Annual Report FY 10-K 2022-12-31 37.00% 56.71% 76.19%
Annual Report FY 10-K 2021-12-31 -27.68% 30.01% 29.52%
Annual Report FY 10-K 2020-12-31 -11.85% -25.10% -31.49%
Annual Report FY 10-K 2019-12-31 61.26% -62.68% -60.71%
Annual Report FY 10-K 2018-12-31 16.72% -123.50% -122.91%
Annual Report FY 10-K 2017-12-31 11495.05% 43.34% 41.44%
Annual Report FY 10-K 2016-12-31 0.00% -123.58% -121.84%
Annual Report FY 10-K 2015-12-31 0.00% -63.95% -62.13%
Annual Report FY 10-K 2014-12-31 0.00% -181.26% -138.12%
Annual Report FY 10-K 2013-12-31 0.00% -60.65% -86.94%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 -15.35% -38.30% 4.07%
Quarterly Report Q2 8-K 2024-06-30 -22.58% 23.18% 3.01%
Quarterly Report Q1 8-K 2024-03-31 -18.74% -7.45% 40.09%
Quarterly Report Q4 8-K 2023-12-31 1.84% 107.01% 126.79%
Quarterly Report Q3 8-K 2023-09-30 -14.13% 74.00% 72.84%
Quarterly Report Q2 8-K 2023-06-30 -55.53% -38.16% -18.42%
Quarterly Report Q1 8-K 2023-03-31 -34.96% 74.77% 57.55%
Quarterly Report Q4 8-K 2022-12-31 -7.42% 87.61% 92.25%
Quarterly Report Q3 8-K 2022-09-30 0.43% 6.40% 12.56%
Quarterly Report Q2 8-K 2022-06-30 139.56% 135.26% 161.56%
Quarterly Report Q1 8-K 2022-03-31 17.96% 4.64% 9.92%
Quarterly Report Q4 8-K 2021-12-31 5.13% 18.76% 22.54%
Quarterly Report Q3 8-K 2021-09-30 -18.72% 0.69% 5.52%
Quarterly Report Q2 8-K 2021-06-30 -41.30% 52.75% 54.35%
Quarterly Report Q1 8-K 2021-03-31 -40.88% -14.54% -9.83%
Quarterly Report Q4 8-K 2020-12-31 -18.48% 7.92% 10.00%
Quarterly Report Q3 8-K 2020-09-30 -34.78% -9.85% -3.92%
Quarterly Report Q2 8-K 2020-06-30 -10.58% -202.13% -192.02%
Quarterly Report Q1 8-K 2020-03-31 21.76% 16.12% 22.17%
Quarterly Report Q4 8-K 2019-12-31 16.22% -6.92% -5.28%
Quarterly Report Q3 8-K 2019-09-30 72.99% -109.56% -100.79%
Quarterly Report Q2 8-K 2019-06-30 106.59% -70.74% -66.91%
Quarterly Report Q1 8-K 2019-03-31 58.21% -209.25% -210.10%
Quarterly Report Q4 8-K 2018-12-31 -31.46% -719.63% -792.96%
Quarterly Report Q3 8-K 2018-09-30 28.79% -12.59% -15.17%
Quarterly Report Q2 8-K 2018-06-30 71.08% -58.33% -61.10%
Quarterly Report Q1 8-K 2018-03-31 120.13% 47.43% 45.53%
Quarterly Report Q4 8-K 2017-12-31 5588.34% 132.43% 129.88%
Quarterly Report Q3 8-K 2017-09-30 0.00% 36.28% 33.18%
Quarterly Report Q2 8-K 2017-06-30 0.00% 39.86% 38.83%
Quarterly Report Q1 8-K 2017-03-31 0.00% -72.66% -72.66%
Quarterly Report Q4 8-K 2016-12-31 0.00% -90.67% -89.75%
Quarterly Report Q3 8-K 2016-09-30 0.00% -86.43% -83.87%
Quarterly Report Q2 8-K 2016-06-30 0.00% -234.73% -232.34%
Quarterly Report Q1 8-K 2016-03-31 0.00% -141.22% -139.04%
Quarterly Report Q4 8-K 2015-12-31 0.00% -91.49% -89.03%
Quarterly Report Q3 8-K 2015-09-30 0.00% -108.33% -105.32%
Quarterly Report Q2 8-K 2015-06-30 0.00% -40.31% -38.89%
Quarterly Report Q1 8-K 2015-03-31 0.00% -10.29% -9.96%
Quarterly Report Q4 8-K 2014-12-31 0.00% -74.34% -71.05%
Quarterly Report Q3 8-K 2014-09-30 0.00% -148.09% -137.58%
Quarterly Report Q2 8-K 2014-06-30 0.00% -169.16% -151.22%
Quarterly Report Q1 8-K 2014-03-31 0.00% -1461.75% -284.57%
Quarterly Report Q4 8-K 2013-12-31 0.00% -82.62% -232.71%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%